Neonatal Point of Care Testing Market Size, Share, Industry, Forecast and outlook (2023-2030)

The neonatal point of care testing market is expected to grow at a high CAGR of 10.8% during the forecast period (2023-2030). This growth is driven by factors such as the rising prevalence of rare diseases, the increasing demand for better healthcare facilities, and the growing adoption of point-of-care testing technologies.

The neonatal point of care testing market is segmented by product, by end-user, and by region. The product segment includes instruments, consumables, and reagents. The end-user segment includes hospitals, clinics, and home care settings. The regional segment includes North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

The key drivers of the neonatal point of care testing market include the rising prevalence of rare diseases, the increasing demand for better healthcare facilities, the growing adoption of point-of-care testing technologies, and the rising awareness of the benefits of early diagnosis and treatment.

The major companies operating in the neonatal point of care testing market include PerkinElmer, Inc., Trivitron Healthcare, Natus Medical Incorporated, Medtronic Plc, Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc., GE Healthcare (General Electric Company), ZenTech S.A., Mp Biomedicals, Baebies, Inc., Masimo, Evancare Medical (Nantong) Co., Ltd., Shenzhen Uni-Medica Technology Co., Ltd. and ShenZhen CAS-Envision Medical Technology Co., Ltd.